Skip to main content
Livermore
Livermore
ZHEN

TLS Advisors LLC

SEC CIK
0001768824
Latest filing
Aug 14, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by TLS Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
30,956
Value
$1.87M
% of portfolio
5.5%
Quarters held
15
Since Q4 2022
Holdings of XENE by TLS Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202630,956$1.87M5.5%00.0%UnchangedHolders
Q1 202630,956$1.80M4.3%+12,098+64.2%AddedHolders
Q4 202518,858$307.0K0.8%−14,098−42.8%ReducedHolders
Q3 202532,956$1.38M4.0%00.0%UnchangedHolders
Q2 202532,956$1.03M3.2%00.0%UnchangedHolders
Q1 202532,956$1.11M2.5%00.0%UnchangedHolders
Q4 202432,956$1.29M3.0%00.0%UnchangedHolders
Q3 202432,956$1.30M2.7%00.0%UnchangedHolders
Q2 202432,956$1.28M3.2%00.0%UnchangedHolders
Q1 202432,956$1.42M3.5%00.0%UnchangedHolders
Q4 202332,956$1.52M5.0%00.0%UnchangedHolders
Q3 202332,956$1.13M4.6%−800−2.4%ReducedHolders
Q2 202333,756$1.30M5.6%00.0%UnchangedHolders
Q1 202333,756$1.21M6.2%00.0%UnchangedHolders
Q4 202233,756$1.33M6.6%–No prior filingHolders